KOSDAQ · Healthcare · ₩176B
₩8,090+3.32%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 11.9% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“진단 제품 확대와 치료제 개발로 사업이 다음 단계에 들어섰어요.”
In the company's words · 2026 2분기 filing